Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit

Risultato della ricerca: Article

Lingua originaleEnglish
pagine (da-a)2505-2525
Numero di pagine21
RivistaInflammatory Bowel Diseases
Volume12
Stato di pubblicazionePublished - 2011

Cita questo

@article{b16c7d8f690241308db7cba28977d0d0,
title = "Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit",
keywords = "Prognostic factors for clinical benefit",
author = "Mario Cottone",
year = "2011",
language = "English",
volume = "12",
pages = "2505--2525",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit

AU - Cottone, Mario

PY - 2011

Y1 - 2011

KW - Prognostic factors for clinical benefit

UR - http://hdl.handle.net/10447/60574

M3 - Article

VL - 12

SP - 2505

EP - 2525

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

ER -